Atlas Trials

EGEN, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch EGEN, Inc.

RecordFirmDate
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients (NCT01300858)EGEN, Inc.2011-06-01
Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer (NCT00473954)EGEN, Inc.2007-04-01
Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer (NCT00137865)EGEN, Inc.2005-08-01

Track EGEN, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.